Alaunos Therapeutics, Inc. (TCRT)
NASDAQ · Manufacturing · Pharmaceutical preparations
$1.08−$0.0500 (−4.42%) on the dayAs of the close; data may be delayed.
TCRT price, last 12 months
Key stats
- Previous close
- $1.13
- Open
- $1.13
- Day range
- $1.08 – $1.13
- 52-week range
- $1.02 – $4.59
- Volume
- 79K
- Avg volume (20 days)
- 2.5M
- Market cap
- $2.8M
Performance
1W−10.0%
1M−39.2%
3M−48.1%
6M−64.1%
YTD−66.6%
1Y−62.1%
vs S&P 500, 1Y−78.9 pts
Technicals and fundamentals
About Alaunos Therapeutics, Inc.
Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a type of fatty liver disease). The program aims to develop a differentiated, non-hormonal, non-incretin approach, unlike hormone-based treatments like GLP-1 drugs. It has a single reportable and operating segment related to biopharmaceutical research and development.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $2.8M